Search

Your search keyword '"GRAVINA, A. G."' showing total 166 results

Search Constraints

Start Over You searched for: Author "GRAVINA, A. G." Remove constraint Author: "GRAVINA, A. G."
166 results on '"GRAVINA, A. G."'

Search Results

2. P464 Could Chat Generative Pre-Trained Transformer (ChatGPT) be an AI-provided friend of the patients for frequently asked questions concerning their IBD management? An evidence- and guidelines-controlled textual analysis of AI-provided outputs

4. P1101 Patient-reported physical activity of IBD patients is of concern when weighed with the international physical activity questionnaire regardless of disease activity and IBD phenotype: barriers and facilitators emerged from the extended "BE-FIT-IBD" cross-sectional study

5. P908 Real-life effectiveness and safety of tofacitinib and vedolizumab as a second-line therapy in anti-TNFs experienced patients ulcerative colitis: preliminary results of an IGIBD study (VE2TO-UC)

7. THE POTENTIAL THERAPEUTIC ROLE OF HERICIUM ERINACEUS EXTRACT IN PATHOLOGIC CONDITIONS INVOLVING THE UROGENITAL-GUT AXIS: INSIGHTS INTO THE INVOLVED MECHANISMS AND MEDIATORS.

8. Role of proton pump inhibitors dosage and duration in Helicobacter pylorieradication treatment: Results from the European Registry on H. pylorimanagement

9. 135 - TENDENCIAS DE PRESCRIPCIÓN DE TRATAMIENTOS ERRADICADORES Y DE SU EFECTIVIDAD EN PACIENTES NAÏVE A LO LARGO DE 10 AÑOS (2013-2022) EN EUROPA: DATOS DEL REGISTRO EUROPEO SOBRE EL MANEJO DE LA INFECCIÓN POR HELICOBACTER PYLORI (HP-EUREG)

10. 123 - OPTIMIZACIÓN DE LA DOSIS DE LOS INHIBIDORES DE LA BOMBA DE PROTONES EN LOS TRATAMIENTOS ERRADICADORES DE PRIMERA Y SEGUNDA LÍNEA FRENTE A HELICOBACTER PYLORI: RESULTADOS DEL REGISTRO EUROPEO SOBRE EL MANEJO DE LA INFECCIÓN POR HELICOBACTER PYLORI (HP-EUREG)

12. Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments

14. Performance of a multicompounds nutraceutical formulation in patients with symptomatic uncomplicated diverticular disease

18. Digestive diseases. 2022-2025 edition

19. Tu1819 REAL-LIFE EFFECTIVENESS AND SAFETY OF TOFACITINIB AND VEDOLIZUMAB AS A SECOND-LINE THERAPY IN ANTI-TNFS EXPERIENCED PATIENTS ULCERATIVE COLITIS: PRELIMINARY RESULTS OF AN IGIBD STUDY (VE2TO-UC)

20. Mo1814 PREVALENCE, ETIOLOGY AND OUTCOME OF ACUTE PANCREATITIS IN INFLAMMATORY BOWEL DISEASE: EUROPEAN PANDORA STUDY

21. Antibiotic resistance prevalence and trends in patients infected with helicobacter pylori in the period 2013–2020: Results of the european registry on h. pylori management (hp-eureg)

22. Corrigendum: Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract (Front. Pediatr., (2021), 9, (697390), 10.3389/fped.2021.697390)

23. Evaluation of the Efficacy and Safety of a Compound of Micronized Flavonoids in Combination With Vitamin C and Extracts of Centella asiatica, Vaccinium myrtillus, and Vitis vinifera for the Reduction of Hemorrhoidal Symptoms in Patients With Grade II and III Hemorrhoidal Disease: A Retrospective Real-Life Study

25. Room for Improvement in the Treatment of Helicobacter pylori Infection: Lessons from the European Registry on H. pylori Management (Hp-EuReg)

26. Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments

27. European Registry on Helicobacter pylori management: Single-capsule bismuth quadruple therapy is effective in real-world clinical practice

28. Management of intracranial hypertension following traumatic brain injury: A best clinical practice adoption proposal for intracranial pressure monitoring and decompressive craniectomy: Joint statements by the Traumatic Brain Injury Section of the Italian Society of Neurosurgery (SINch) and the Neuroanesthesia and Neurocritical Care Study Group of the Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI)

29. Management of intracranial hypertension following traumatic brain injury: A best clinical practice adoption proposal for intracranial pressure monitoring and decompressive craniectomy: Joint statements by the Traumatic Brain Injury Section of the Italian Society of Neurosurgery (SINch) and the Neuroanesthesia and Neurocritical Care Study Group of the Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI)

30. Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial

31. P559 Efficacy of Ustekinumab in the treatment of patients with Crohn’s disease with failure to previous conventional or biologic therapy: an observational real-life study

33. European Registry on Helicobacter pylori management: Single-capsule bismuth quadruple therapy is effective in real-world clinical practice

34. Extra-Gastric Manifestations of Helicobacter pylori Infection

35. Critical review on the use and abuse of alcohol. When the dose makes the difference

36. Light Alcohol Drinking and the Risk of Cancer Development: A Controversial Relationship

38. Urotensin II receptor expression in patients with ulcerative colitis: a pilot study

42. EFFICACY OF USTEKINUMAB IN THE TREATMENT OF PATIENTS WITH CROHN'S DISEASE WITH FAILURE TO PREVIOUS CONVENTIONAL OR BIOLOGIC THERAPY: A PROSPECTIVE OBSERVATIONAL REAL-LIFE STUDY.

45. The “three-in-one” formulation of bismuth quadruple therapy forHelicobacter pylorieradication with or without probiotics supplementation: Efficacy and safety in daily clinical practice

46. European Registry on Helicobacter pylorimanagement: Single‐capsule bismuth quadruple therapy is effective in real‐world clinical practice

47. Cyclic vomiting in a young patient with superior mesenteric artery syndrome

48. Autoimmune thyroid disease and neuroendocrine gastric tumors: early detection and efficacy of somatostatin analogue treatment

49. Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer?

Catalog

Books, media, physical & digital resources